PersTIgAN project

Guidance predicting therapy response in IgAN is currently lacking although controlled studies have yielded reductions in proteinuria. To serve this urgent need, the project aims at developing an urine-proteomic biomarker-based algorithm that predicts immunosuppressive drug response in IgAN, personalizing intervention and significantly improving patient management.


This project was funded by the ERA-NET PerMed programme (Ref. No. ERAPERMED2018-217) co-funded by the European Commission and the national funding agencies.